January 10-13, 2026 at The Grand Hyatt Deer Valley in Park City, Utah The LUGPA 2026 Global Prostate Cancer Congress provides a comprehensive overview of best practices in the prevention, detection, management and treatment of prostate cancer. The program is designed by LUGPA in conjunction with Specialty Networks as a live in-person meeting to serve an audience of urology and oncology learners. This continuing medical education program has been designed to cover the latest research and cutting edge topics in prostate cancer and to provide an opportunity to ski and enjoy resort activities.
Dr. Crawford Invites you to Attend
Program chair: E. David Crawford, MD (center); co-chairs: Scott B. Sellinger, MD (left), David Morris, MD (right)
Topics include:
Care of the Whole Cancer Patient – addressing diet and the microbiome, testosterone therapy considerations, APP-directed clinics, and the caregiver/patient perspective.
Advances in Diagnostics and Imaging – featuring new biopsy techniques, PSMA-guided approaches, pre-biopsy markers, PTEN testing, artificial intelligence, and the latest in PET/MRI applications.
Genetics and Genomics – exploring biomarkers in screening, the role of AI in genomic interpretation, and strategies for treatment deintensification.
Localized and Hormone-Sensitive Prostate Cancer – covering advances in radiation, surgical modifications, managing incontinence, ADT updates, and evolving approaches to multimodal therapy.
CRPC and Next-Line Therapy – including updates on radioligand therapy, PARP inhibitors, and the role of somatic testing upon progression.
Health Policy and Advocacy – with leading experts examining the impact of policy and regulation on patient care and practice management.
Management of ADT Side Effects and Survivorship – practical approaches led by APPs, alongside updates on comprehensive patient care strategies.
In addition to the educational sessions, the Congress includes networking receptions, industry-supported symposia, and dedicated exhibit hall time designed to connect attendees with peers, thought leaders, and industry partners. Built-in breaks throughout the program allow participants to enjoy the unique resort setting—whether skiing on the Deer Valley slopes, relaxing with colleagues, or attending evening social events such as Industry Night and cocktail receptions.
The balance of cutting-edge science, practical education, and collegial networking in a world-class winter destination makes this a truly distinctive meeting experience.
Registration is now open for LUGPA members and non-members to attend the Global Prostate Cancer Congress. While the 35 complimentary seats have been filled, LUGPA members can still secure their spot at the special member rate of $500 (non-members: $800). Reserve your hotel room at the exclusive LUGPA group rate of $599 per night (plus tax and resort fee) before the room block closes on December 12, 2025.
Join colleagues from across the country for an important gathering focused on the latest advances in prostate cancer care. Don’t miss this opportunity to connect, learn, and bring valuable insights back to your practice.
CME will be Made Available ! This program will be certified for AMA PRA Category 1 Credit™. The total number of credits available will be based on the overall hours of accredited education offered during the program. Attendees will be able to claim credit reflecting their participation.
Call for Abstracts Now Open
LUGPA is now accepting abstracts for the 2026 Global Prostate Cancer Congress.
We will welcome submissions from members, non-members, residents, and industry professionals on topics including:
Clinical strategies for managing prostate cancer
Original research or outcomes data
Novel treatments or technologies
Case-based learning
Accepted presenters will be invited to submit a 2–3 minute video of their abstract to be played during the meeting—no need to attend in person. Deadline to submit is Oct. 8, 2025.
Read about the 2025 Global Prostate Cancer Congress here.
If you have any questions, please contact Katherine Stack, [email protected]. Industry partners who have questions can contact Rachel Rusch, [email protected].
